Cagrilintide + Semaglutide Peptide Pen (12mg)
The Cagrilintide + Semaglutide Peptide Pen (12mg) contains Cagrilintide (2.4mg) and Semaglutide (9.6mg) in a premium Alstra Med pre-filled multidose pen system. The ready-to-use formulation provides convenient and precise dosing without the need for mixing or reconstitution.
Additionally, the pen features an 80-click dosing system with a 2.6mL cartridge, supporting consistent administration while reducing preparation time. The multidose design provides a practical peptide delivery system for use as part of a professionally guided wellness programme.
Furthermore, researchers have investigated Cagrilintide and Semaglutide for their interaction with appetite regulation, satiety signalling, and metabolic pathways. A qualified healthcare professional should determine whether this peptide combination is appropriate based on an individual’s medical history, treatment goals, and clinical circumstances.
Moreover, the ready-to-use Alstra Med pen provides a convenient multidose format that supports consistent preparation and administration.
Active Ingredients
Cagrilintide – 2.4mg
Researchers have investigated Cagrilintide, an amylin analogue, for its interaction with appetite regulation and satiety signalling. Additionally, ongoing research continues to explore its role in professionally supervised wellness programmes.
Semaglutide – 9.6mg
Researchers have investigated Semaglutide, a GLP-1 receptor agonist, for its interaction with appetite regulation and metabolic pathways. Furthermore, qualified healthcare professionals may include Semaglutide within appropriate wellness or medical programmes where suitable.
Features
- Pre-filled peptide pen containing Cagrilintide and Semaglutide
- Precision 80-click dosing system
- Ready-to-use formulation
- No mixing or reconstitution required
- Convenient multidose pen
- Professional Alstra Med presentation
- Designed for use under qualified healthcare supervision
What’s Included
- 1 × Pre-filled peptide pen containing Cagrilintide (2.4mg) and Semaglutide (9.6mg)
- 1 × Alstra Med branded presentation box
- 8 × Sterile single-use pen needles
Information
Product: Cagrilintide + Semaglutide Peptide Pen
Brand: Alstra Med
Total Strength: 12mg
Active Ingredients
- Cagrilintide – 2.4mg
- Semaglutide – 9.6mg
Cartridge Volume: 2.6mL
Formulation: Pre-filled multidose peptide pen
Directions for Use
Before use, read the enclosed product leaflet carefully. Then follow the recommended dosage, administration, and storage instructions supplied with the product. Afterwards, use the pen only as directed by your qualified healthcare professional. Finally, continue to follow all storage instructions provided with the product.
Consult a qualified healthcare professional before using this product to determine whether it is appropriate for your individual medical circumstances.
Who Should Not Use This Product
Do not use this product unless advised by a qualified healthcare professional if you:
- Are pregnant or breastfeeding.
- Are under 18 years of age.
- Have a known allergy or sensitivity to Cagrilintide, Semaglutide, or any ingredient in the formulation.
- Are taking prescription medication or managing a medical condition requiring medical supervision.
- Have a medical condition where GLP-1 receptor agonists or amylin analogues may not be appropriate.
If you experience unexpected or adverse effects, discontinue use and seek medical advice promptly.
Storage Instructions
- Store refrigerated according to the supplied product instructions.
- Do not freeze.
- Protect from direct sunlight and excessive heat.
- Keep the pen cap securely fitted when not in use.
- Keep out of reach of children.
- Follow the storage guidance supplied with the enclosed product leaflet.
Product Identification Notice
This page describes a peptide pen formulation containing Cagrilintide (2.4mg) and Semaglutide (9.6mg) supplied by Alstra Med.
The use of the term “CagriSema” within product references is intended only as a descriptive identifier where applicable. This product is not represented as, and should not be interpreted to be, the official Novo Nordisk investigational medicine or an official Novo Nordisk product.
Health Disclaimer
Products sold by Peptide Pen Lounge are intended for wellness and lifestyle support purposes only and are not intended to diagnose, treat, cure, or prevent any disease.
The Cagrilintide + Semaglutide Peptide Pen should only be used under the guidance of a qualified healthcare professional. A healthcare professional should determine whether this product is appropriate based on your individual medical history, medications, and treatment requirements.
Always consult a qualified healthcare professional before use, especially if you are pregnant, breastfeeding, under 18 years of age, taking prescription medication, or managing a medical condition.
Individual results may vary. Therefore, use only as directed and under appropriate professional guidance.
